Optimizing Asthma Control: Individualizing Therapy

Title:

Optimizing Asthma Control: Individualizing Therapy

Topic: Pulmonary Disease
Relevant Terms: Asthma, tailoring treatment, patient education
Primary Audience: Primary care clinicians, community pulmonologists, allergists, and others involved in the management of patients with asthma.
Launch Date: 30-Aug-16
Credits: AMA PRA Category 1 Credit
Expiration Date: 30-Aug-17
Curriculum Name: Point of Care Clinical Decisions in Asthma Management

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Develop guideline-recommended treatment plans for patients with asthma based on disease severity.
  2. Individualize treatment for patients with moderate to severe persistent asthma.
  3. Adjust asthma treatment as necessary based on assessment of asthma control.
  4. Provide patients with the education and tools to engage them as active partners in their asthma care.

    Faculty

    Monica Kraft, MD
    Professor of Medicine
    Chair, Department of Medicine
    The Robert and Irene Flinn Endowed Chair of Medicine
    University of Arizona
    Tucson, AZ
    Michael E. Wechsler, MD, MMSc
    Director, Asthma Program
    Professor of Medicine
    Division of Pulmonary, Critical Care & Sleep Medicine
    Department of Medicine                                            
    National Jewish Health
    Denver, CO
    DISCLOSURES
    Michael E Wechsler, MD, MMSc, discloses the following relationships with commercial interests: 
    Consultant--Sanofi, AstraZeneca, Novartis, Teva, Genentech, Theravance, Vectura, Mylan, Regeneron, Boston Scientific, Meda, Tunitas

    Monica Kraft, MD, discloses the following relationships with commercial interests: 
    Consultant--Teva, AstraZeneca, Genentech
    Grant Funding--Roche, Sanofi, Chiesi

    Rick Ricer, MD, Physician Reviewer, University of Cincinnati, has no conflicts of interest to disclose. 
    Susan P. Tyler, MEd, CMP, CHCP, FACEHP, University of Cincinnati, has no conflicts of interest to disclose. 
    Joshua Kilbridge, Medical Writer, has no conflicts of interest to disclose.
    Kathleen Hines, Vice President, Editorial Services, MCM Education, has no conflicts of interest to disclose. 
    Terry Ann Glauser, MD, MPH, Vice President, Medical Affairs, MCM Education has no conflicts of interest to disclose. 

    The University of Cincinnati requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications. 

    In this educational activity, the faculty reports their presentation will not contain reference to investigational and/or off-label uses.

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    CREDIT STATEMENTS
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians. 

    The University of Cincinnati designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Release date: August 30, 2016 
    Last review date: August 30, 2016 
    Expiration date: August 30, 2017

    COMMERCIAL SUPPORT STATEMENT
    This activity is supported by an educational grant from Novartis.
     
    HOW TO RECEIVE CREDIT
    To receive credit, users must:
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the activity evaluation.
    Physicians, nurse practitioners, and physician assistants who score 80% or higher on the post-test and complete the evaluation will receive CME credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1  
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 6.0+ for Mac OSX 10.7 and above
     

    DISCLAIMER
    © 2016 MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the University of Cincinnati, or Novartis. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer's product information, and comparing any therapeutic approach with the recommendations of other authorities.